BIO200H5 Study Guide - Comprehensive Final Exam Guide - Enzyme, Cell Surface Receptor, Protein
Document Summary
Slide 11: do(cid:374)"t have to re(cid:373)e(cid:373)ber the defi(cid:374)itio(cid:374)s of these ter(cid:373)s, some genetic variations make some individuals more susceptible to have side effects with certain drugs than other group of individuals. Slide 16: they were matching drugs with targets, modern pharmacology. Slide 18: acetanilide was a by-product, produced first synthetic drug, did(cid:374)"t have to fi(cid:374)d it i(cid:374) (cid:374)ature, from this experience, they wanted to find more by-products to use. Slide 19: this is how they made aspirin. Slide 20: all of these drugs were used without knowing their targets. Slide 21: combining these 2 fields will lead to treating, diagnosing and preventing diseases, this is how clinical trials arose. Slide 23: all drugs can be toxic. Slide 24: any chemical compound as a drug will inhibit or activate biological processes, agonists, activate a biological process, antagonists. Inhibit a biological process: these can be any of these categories, what is the difference between poisons and toxins, they are both harmful.
